Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Parkin disease: a phenotypic study of a large case series.
Khan NL, Graham E, Critchley P, Schrag AE, Wood NW, Lees AJ, Bhatia KP, Quinn N. Khan NL, et al. Among authors: critchley p. Brain. 2003 Jun;126(Pt 6):1279-92. doi: 10.1093/brain/awg142. Brain. 2003. PMID: 12764051
Young onset Parkinson's disease.
Quinn N, Critchley P, Marsden CD. Quinn N, et al. Among authors: critchley p. Mov Disord. 1987;2(2):73-91. doi: 10.1002/mds.870020201. Mov Disord. 1987. PMID: 3504266
Tracking Parkinson's: Study Design and Baseline Patient Data.
Malek N, Swallow DM, Grosset KA, Lawton MA, Marrinan SL, Lehn AC, Bresner C, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG; PRoBaND. Malek N, et al. J Parkinsons Dis. 2015;5(4):947-59. doi: 10.3233/JPD-150662. J Parkinsons Dis. 2015. PMID: 26485428 Free PMC article.
Antiparkinsonian activity of a single oral dose of PHNO.
Grandas F, Quinn N, Critchley P, Rohan A, Marsden CD, Stahl SM. Grandas F, et al. Among authors: critchley p. Mov Disord. 1987;2(1):47-51. doi: 10.1002/mds.870020106. Mov Disord. 1987. PMID: 2904120
When should levodopa be started?
Quinn N, Critchley P, Parkes D, Marsden CD. Quinn N, et al. Among authors: critchley p. Lancet. 1986 Oct 25;2(8513):985-6. doi: 10.1016/s0140-6736(86)90642-2. Lancet. 1986. PMID: 2877169 No abstract available.
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group. Gray R, et al. JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. JAMA Neurol. 2022. PMID: 34962574 Free PMC article. Clinical Trial.
(+)-4-Propyl-9-hydroxynaphthoxazine in Parkinson's disease.
Grandas Perez FJ, Jenner PG, Nomoto M, Stahl S, Quinn NP, Parkes JD, Critchley P, Marsden CD. Grandas Perez FJ, et al. Among authors: critchley p. Lancet. 1986 Apr 19;1(8486):906. doi: 10.1016/s0140-6736(86)91004-4. Lancet. 1986. PMID: 2870368 No abstract available.
Psychosis and the lisuride pump.
Critchley P, Grandas Perez F, Quinn N, Coleman R, Parkes D, Marsden CD. Critchley P, et al. Lancet. 1986 Aug 9;2(8502):349. doi: 10.1016/s0140-6736(86)90042-5. Lancet. 1986. PMID: 2874361 No abstract available.
Domperidone.
Critchley P, Langdon N, Parkes JD, Quinn NP, Shindler JS, Marsden CD. Critchley P, et al. Br Med J (Clin Res Ed). 1985 Mar 9;290(6470):788. doi: 10.1136/bmj.290.6470.788-b. Br Med J (Clin Res Ed). 1985. PMID: 3918756 Free PMC article. No abstract available.
82 results